Engflag

Tanac Liquid

Quick links to important sections

Tanac Liquid

Tanac Liquid_EN

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tanac Liquid

Property Description
Active ingredients Benzocaine, Tannic Acid, Benzalkonium Chloride
Form Topical liquid solution
Pharmacological class Oral mucosal analgesic, Antiseptic, Astringent combination
Common purpose Symptomatic relief of minor oral discomfort
Origin Synthetic and naturally derived blend

What Type of Medicine is Tanac Liquid?

Tanac Liquid is defined as an Over-The-Counter (OTC), multi-component topical liquid solution intended for direct application to the oral mucosal tissues. The preparation belongs to the pharmacological classification of a combination medication, uniquely integrating three distinct actions. It functions as an oral mucosal analgesic, a topical antiseptic, and an astringent preparation. The active substance Benzocaine is a recognized local anesthetic, providing the product's foundation in localized pain management.

Composition and General Purpose

The distinctive identity of Tanac Liquid stems from its triple-action blend of active ingredients: the synthetic anesthetic Benzocaine, the naturally derived astringent Tannic Acid, and the synthetic antiseptic Benzalkonium Chloride. The formula’s inclusion of Tannic Acid is a key differentiating feature; its capacity for protein precipitation facilitates the temporary protection of the superficial mucosal layer. The general purpose of this composition is the immediate and temporary management of minor oral discomfort through combined oral pain relief, tissue protection, and local germ-reducing action. The product is specifically formulated as a liquid for targeted application to the affected oral area.

What side effects are possible with Tanac Liquid?

Possible Side Effects and Safety Information

The safety profile of Tanac Liquid, a product containing topical benzocaine, tannic acid, and benzalkonium chloride, is officially documented across several regulatory domains. The safety information focuses on potential adverse reactions and specific usage restrictions, reflecting the classifications found in government sources.

Serious Systemic Safety Considerations

The most serious reaction officially noted in regulatory documentation for topical benzocaine is Methemoglobinemia. This condition, classified as rare but serious, affects the Blood and Lymphatic System, leading to a reduction in the blood's ability to carry oxygen. Symptoms associated with this reaction, as listed in labeling, may include changes in skin color, such as pale, gray, or blue-colored skin (cyanosis), along with headache, rapid heart rate, shortness of breath, dizziness, or fatigue. Symptoms can manifest quickly, often within minutes to one or two hours after application, even if the product has been previously used without issue.

Localized and Hypersensitivity Reactions

Adverse reactions that are possible at the site of application include localized irritation, pain, or redness. The product labeling also documents signs of potential severe allergic reactions (hypersensitivity), such as the development of swelling, rash, or fever.

Population-Specific Safety Constraints

Use of the product is explicitly advised against for children under 2 years of age. Furthermore, the liquid is contraindicated for individuals with a history of allergy to "caine" type local anesthetics. Official statements recommend that pregnant or breast-feeding individuals consult a health professional prior to use. Additionally, due to its composition, the liquid includes an official warning regarding flammability.

Overdose and Emergency Response

The official overdose profile for Tanac Liquid is structured around the potential for systemic toxicity, specifically the serious and potentially fatal condition known as Methemoglobinemia, associated with the Benzocaine component. Over-exposure, excessive application, or accidental ingestion mandates immediate intervention.

Overdose Manifestations Mandated Emergency Action
Systemic Symptoms: Cyanosis (pale, gray, or blue skin/lips), Dyspnea (shortness of breath), Tachycardia (rapid heart rate), Dizziness, and unusual Fatigue. Seek immediate medical attention or contact a Poison Control Center right away if any suspected overdose or symptom presentation occurs.
Gastrointestinal Symptoms: Vomiting and severe abdominal pain following accidental ingestion of large volumes. Hospital monitoring may be required for severe systemic effects, including continuous cardiorespiratory monitoring.

Regulatory documents define this condition as a high-level concern that requires urgent care. The FDA explicitly warns that infants and children younger than two years are at a seriously increased risk for Methemoglobinemia and should not use the product. Management of symptomatic Methemoglobinemia involves the administration of the specific antidote, Methylene Blue, and supportive treatment. These official statements define when urgent medical help must be sought.

Therapeutic Uses of Tanac Liquid

What Tanac Liquid Treats: Main Uses and Benefits

Topical products containing oral anesthetics are commonly used in situations involving certain distressing symptoms, such as the localized discomfort associated with specific mouth conditions.

Supportive Management for Painful Oral Sores

Tanac Liquid is applied across domains where additional symptomatic support is needed for conditions involving acute or disruptive episodes. It is commonly used to help with symptom clusters that may become intense or disruptive, and is applied in addressing the soreness associated with canker sores, cold sores, and fever blisters. This application supports the patient during difficult episodes by easing the overall symptom load and contributes to support the patient's general well-being during periods of heightened symptoms.

“The product is commonly used to offer symptomatic support that may help patients cope with distressing manifestations.”

Relief for Minor Gum and Mouth Irritations

The product is relevant when supportive symptom management is appropriate for conditions involving recurrent or episodic manifestations, such as minor irritations or injury of the mouth and gums. Often used during phases when symptoms become more noticeable, this liquid may assist in maintaining functional stability by being applied in addressing temporary localized discomfort and may assist with maintaining comfort when symptoms interfere with routine activities.

Quick Fact: Relief for Localized Oral Discomfort
Commonly used for: Symptomatic discomfort, tenderness, and irritation associated with oral lesions.
Symptomatic benefit: Contributes to easing the overall symptom load.

Regulatory References

  1. Label: WALGREENS MOUTH SORE RELIEF- benzocaine liquid - DailyMed

Eligibility and Restrictions for Use

Who Can and Cannot Use Tanac Liquid?

The population eligibility for Tanac Liquid is defined by official regulatory documentation, focusing on age limitations, pre-existing conditions, and known sensitivities.

Contraindicated and Restricted Use

Classification Rule
Absolute Contraindication Use is strictly prohibited for children younger than 2 years of age due to the risk of methemoglobinemia.
Individuals with a known allergy or hypersensitivity to benzocaine or other "caine"-type local anesthetics must not use this product.
Restricted Use Pregnant or breast-feeding patients must seek the advice of a health professional before use, as mandated by official labeling.

Age and Comorbidity Eligibility

Tanac Liquid is approved for use by adults and children 2 years of age and older (children under 12 require adult supervision).

Regulatory warnings note that use should be approached with caution in patients with specific health risk factors. These include those with underlying heart disease, lung or breathing problems (such as asthma or emphysema), or hereditary metabolic disorders affecting the blood. Such conditions increase the documented risk profile associated with the active ingredient. The product is also explicitly restricted from use for the purpose of treating teething pain.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes officially documented interaction patterns for the active ingredients in this topical liquid solution, as defined by government regulatory sources.

Drug-Drug Interactions

The Benzocaine component is associated with pharmacodynamic interactions that can increase the risk of methemoglobinemia. Co-administration with agents such as Dapsone or certain Nitrate Derivatives (including Nitroglycerin) is documented to enhance this risk through an additive toxic effect. Furthermore, the official label includes a formal contraindication against use in patients with a known hypersensitivity to Benzocaine or other ester-type local anesthetics.

Administration-Timing and Exposure Rules

Interacting Substance Official Outcome/Rule
Oral Medications Decreased absorption and effectiveness of the oral drug. To mitigate, take oral drugs at least one hour after application.
Fruit Juices/Soft Drinks May cause deactivation of the antiseptic component. Avoid consumption for at least one hour after application.

These time-based rules are necessary to manage the exposure-altering potential of the Tannic Acid component, which may bind to substances and reduce the systemic bioavailability of co-administered oral medications. Separately, the Benzalkonium Chloride component is susceptible to deactivation by specific beverages.

Mechanism of Action

Tanac Liquid operates through a triple-action mechanistic profile, targeting three distinct physiological processes simultaneously to modulate local nociceptive signaling and influence superficial tissue structure. The combined physiological consequence results from complementary peripheral actions: inhibition of nerve conduction, protein precipitation, and microbial membrane disruption, each driven by a unique active component.

Peripheral Interruption of Sensory Impulse Conduction

This mechanism is driven by Benzocaine, a local anesthetic that works by directly targeting Voltage-Gated Sodium Channels ( Na V) on sensory nerve endings. By binding and blocking these channels, Benzocaine physically prevents the necessary influx of sodium ions required for the nerve to generate an electrical impulse. This action leads to localized membrane stabilization, arresting the propagation of the sensory impulse at the source and preventing its transmission to the CNS.

️ Physical Stabilization and Constriction of Oral Mucosa

The Tannic Acid component exerts an astringent mechanism based on a chemical reaction with the surface layer of the oral tissue. It rapidly binds to and precipitates mucoproteins and surface glycoproteins, creating a thin, protective protein coagulum. This physical barrier constricts the underlying superficial tissue and reduces local permeability, which results in reduced tissue fluid exudation and decreased excitability of superficial nerve endings.

Rapid Local Microbial Cell Membrane Disruption

The third mechanism involves Benzalkonium Chloride, an antiseptic surfactant. This cationic molecule works by integrating itself into the lipid bilayer and structural proteins of microbial cell membranes. This process severely disrupts the membrane integrity, leading to leakage of cytoplasmic contents and rapid cell lysis. The physiological consequence is a reduction in the local microbial load due to cytolytic action on microbial structures.

Dosage and Administration Information

Tanac Liquid is administered exclusively via topical application to the oral mucosal tissues. The product, a liquid solution containing Benzocaine 10%, is formulated for direct, localized application to the affected area. The standard method of administration requires using a clean fingertip or a cotton swab to deliver a small amount of the solution precisely where needed. This localized method is intended to ensure proper use of the liquid within the mouth.

The usage pattern for the liquid is a short-term, intermittent treatment. The medicine is intended for use as needed for temporary symptomatic relief, with a maximum frequency of up to 4 times daily. Furthermore, a limitation exists on the duration of self-administration: the liquid must not be used for more than 7 days unless instruction is provided by a dentist or doctor.

Usage is subject to specific age-based constraints. The product is for use in adults and children 2 years of age and older. Administration to children under the age of 12 requires adult supervision, and the product is prohibited for use in children under 2 years of age. This procedural framework structures the liquid as a strictly constrained, symptomatic intervention.

Administration Constraints
Route of Administration Topical to the Oral Mucosa
Maximum Frequency Up to 4 times daily
Duration of Use Do not use for more than 7 days
Age Restriction Not for use in children under 2 years old

Recent Clinical Evidence

Evidence for the Core Indication: Localized, Temporary Oral Pain Relief

Research into the main ingredient, the local anesthetic Benzocaine, was studied for its effects in research exploring how symptoms change over time. The regulatory foundation relies on decades of accumulated evidence summarized in the FDA OTC Monograph Review, which classifies this ingredient. Research examined patient-reported outcomes describing perceived discomfort in acute conditions. Studies focused on short-term symptom changes, tracking outcomes like perceived discomfort and changes in localized perception over limited time intervals.

Supportive Evidence: Astringent and Antiseptic Components

The liquid preparation includes the ingredients Tannic Acid (an astringent) and Benzalkonium Chloride (an antiseptic). These were evaluated in laboratory and physiochemical mechanism studies; clinical trials focusing on patient-reported symptom change are less common. Research examined the antiseptic component's ability to affect microbial growth and the astringent component's ability to cause protein precipitation, which is studied for temporary tissue protection.

Component-Level vs. Combination-Product Evidence

Evidence for the individual actions primarily describes established pharmacological patterns. Research limitations indicate that evidence is limited for the specific combination product. There is limited comparative evidence for the triple-component liquid against a single-component product; consequently, data for observed population symptom patterns are insufficient.

Research Landscape in Special Populations

Research has explored the use of the main anesthetic ingredient in adults and adolescents. Regulatory reviews note the limited clinical data available for children under a certain age (often under 2 years), contributing to limitations in the research summary for this population. Follow-up durations were limited to acute relief, and results apply only to the populations studied.

Long-Term Outcomes and Durability of Effect

The existing research is relevant in trials assessing short-term or episodic symptom patterns. Long-term effects are not fully established for maintenance or durability of effect, and long-term outcomes related to chronic conditions are not well characterized. Research continues to explore topical analgesics to provide further context.

Main Evidence Gaps and Areas of Uncertainty

Evidence highlights what is known — and what is still uncertain regarding the specific triple-combination liquid. Comparative evidence is lacking, and evidence quality varies across studies. The main limitations include short follow-up durations and the fact that most data describe the individual components’ actions rather than the overall clinical contribution of the full formulation in human trials.

Key Studies & References WALGREENS MOUTH SORE RELIEF- benzocaine liquid - DailyMed Label

Frequently Asked Questions (FAQ)

Common questions about Tanac Liquid (FAQ)

Q: Is Tanac Liquid only meant to treat canker sores?

According to official product information, Tanac Liquid is indicated to temporarily relieve pain due to a variety of minor oral issues. This includes pain from canker sores, cold sores, fever blisters, and minor irritations or injury of the mouth and gums.

Q: Can Tanac Liquid be used for general mouth irritation from braces?

The official labeling indicates the product is intended for the temporary relief of pain from minor irritations of the mouth and gums. Although specific causes like braces irritation are not named, this general indication applies to minor oral discomfort.

Q: Is this product intended for use on cold sores or fever blisters?

Yes, regulatory documents state that the product is officially indicated for the temporary relief of pain due to both cold sores and fever blisters.

Q: What specific oral injuries is Tanac Liquid intended to relieve pain from?

Official documents state that the product is intended to relieve pain associated with canker sores, cold sores, fever blisters, and minor irritations or injury of the mouth and gums.

Q: Does Tanac Liquid help with discomfort caused by denture irritation?

The specific Tanac label lists pain from 'minor irritations' as an indication for use. Similar benzocaine oral pain relievers found in official government monographs are labeled for pain related to denture irritation.

Q: Is Tanac Liquid intended for pain from a dental procedure?

The product is indicated for temporary relief of pain from minor irritations or injury of the mouth. This intent aligns with the purpose of similar benzocaine products which are explicitly labeled for minor pain following dental procedures.

Q: How quickly can a user expect to feel the pain relief after application?

Studies have examined the time to onset of pain-relieving effects, with research on the active anesthetic ingredient, benzocaine, indicating this often begins in less than one minute after application.

Q: How long does the pain relief from Tanac Liquid usually last?

Studies investigating the duration of the anesthetic effect of benzocaine generally describe the effect lasting for approximately five to ten minutes.

Q: What is the difference between Tanac Liquid and Tanac No Sting Liquid?

Regulatory labels for both the standard liquid and the 'No Sting' liquid indicate that they contain the same active ingredient (Benzocaine 10%) and are intended for the same uses.

Q: What is the purpose of the inactive ingredients listed on the label?

The official label lists several inactive ingredients, such as propylene glycol and polyethylene glycol 400. These components primarily serve formulation purposes, such as ensuring the liquid's proper solubility and stability.

Q: Is it okay if I accidentally swallow a small amount of Tanac Liquid?

The product is exclusively intended for topical use in the mouth. Official labeling includes a mandatory warning to seek medical help or contact a Poison Control Center right away in the event of accidental ingestion or overdose.

Q: What should I do if my symptoms clear up and occur again within a few days?

Official product information states that consultation with a doctor or dentist is warranted if symptoms clear up and occur again within a few days.

Q: Is a slight burning or tingling sensation a normal initial feeling when applied?

The product warnings indicate that localized irritation, pain, or redness are possible reactions. The warnings state that consulting a doctor or dentist is necessary if irritation, pain, or redness persists or worsens after application.

Q: Are there different concentrations of the active ingredient available in Tanac Liquid?

The specific Tanac Oral Pain Reliever liquid listed in official regulatory labeling contains Benzocaine 10%.

Q: Does the product contain any type of alcohol?

The official label for the 10% liquid lists inactive ingredients, including propylene glycol and polyethylene glycol 400. The label does not list Ethanol or Benzyl Alcohol.

Q: Is Tanac Liquid considered an oral pain reliever or a treatment for the sore itself?

The product is officially defined as an Oral Pain Reliever. It is intended to provide temporary symptomatic relief from pain and discomfort in the mouth.

Q: Is Tanac Liquid the same as an antiseptic mouthwash?

Tanac Liquid is classified as a multi-component topical liquid. It functions as a combination of an oral pain reliever, an astringent, and an antiseptic, which makes it distinct from a general antiseptic mouthwash.

Q: What should be done if the sore mouth symptoms do not improve within 7 days?

Official labeling provides a statement that consultation with a doctor or dentist is necessary if the sore mouth symptoms do not show improvement within seven days.

Q: Can Tanac Liquid cause any temporary numbness in the mouth beyond the treated area?

The active ingredient, benzocaine, is a local anesthetic intended to block nerve signals and provide relief localized to the site of application. The label does not specifically address numbness spreading beyond the area of contact.

Q: Why is Tanac Liquid not recommended for children under 2 years of age?

Official warnings state that use in children under two years of age is prohibited. This restriction is due to the documented potential for methemoglobinemia, a serious condition that affects the blood’s ability to carry oxygen.

Q: Is it generally known to interact with certain prescription medications?

Yes, regulatory warnings indicate known interactions with certain prescription medications. For instance, co-administration with Dapsone and specific Nitrate Derivatives can increase the risk of methemoglobinemia.

Q: Does the inclusion of Tannic Acid in some products change its primary function?

The inclusion of Tannic Acid contributes an astringent action that is studied for temporary tissue protection. This mechanism supports the overall primary purpose of temporary oral pain relief.

Q: Can Tanac Liquid be applied to cuts or irritation on the skin outside of the mouth?

Regulatory labeling explicitly states that the product is For oral use only.

Q: Why is the product intended for oral use only?

The product's primary mechanism of action is designed for topical application to the oral mucosal tissues. The ingredients are formulated to relieve pain and provide localized protection specifically in the mouth area.

Q: Is Tanac Liquid suitable for use on the roof of the mouth or the throat area?

The product is indicated for application to the oral mucosa, which includes the mouth and gums. The label specifies the product is intended for use in the mouth only.

Q: What does the term 'Oral Pain Reliever' mean for this product?

The term 'Oral Pain Reliever' means that the product is intended to provide temporary relief from minor pain and discomfort associated with oral irritations.

Q: Is there a specific way the product is supposed to adhere or coat the sore?

The official mechanism of action for the astringent component, Tannic Acid, describes it as creating a physical, protective protein coagulum, or barrier, over the affected surface.

How should Tanac Liquid be stored and disposed of?

How to Store and Dispose of Tanac Liquid?

Tanac Oral Pain Reliever liquid must be stored according to the requirements specified in the official regulatory labeling to ensure product stability and safety.

Storage Requirements

The product must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C (68 F to 77 F). The label includes a Flammability warning and mandates that the product be kept away from fire or flame. For safety, it is also a mandatory instruction to Keep out of reach of children.

Disposal Instructions

Official government labeling does not provide specific product instructions for the household disposal of unused Tanac liquid. In the absence of a defined method, users should dispose of any unused or expired product by following local regulations or community drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Tanac Liquid found in:

A-Z Index: